Millennium Management LLC Trims Stake in TransEnterix, Inc. (TRXC)

Millennium Management LLC decreased its holdings in shares of TransEnterix, Inc. (NYSEAMERICAN:TRXC) by 82.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 213,532 shares of the medical instruments supplier’s stock after selling 984,222 shares during the period. Millennium Management LLC owned approximately 0.11% of TransEnterix worth $412,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of TRXC. Raymond James Financial Services Advisors Inc. bought a new position in shares of TransEnterix during the 4th quarter valued at about $113,000. Bank of New York Mellon Corp boosted its position in shares of TransEnterix by 94.0% during the 4th quarter. Bank of New York Mellon Corp now owns 119,584 shares of the medical instruments supplier’s stock valued at $231,000 after purchasing an additional 57,944 shares in the last quarter. BlackRock Inc. boosted its position in shares of TransEnterix by 157.3% during the 4th quarter. BlackRock Inc. now owns 1,760,266 shares of the medical instruments supplier’s stock valued at $3,397,000 after purchasing an additional 1,076,133 shares in the last quarter. Virtu Financial LLC bought a new position in shares of TransEnterix during the 4th quarter valued at about $109,000. Finally, EAM Investors LLC acquired a new position in shares of TransEnterix in the fourth quarter worth about $1,333,000.

Shares of TransEnterix opened at $2.85 on Friday, according to Marketbeat Ratings. TransEnterix, Inc. has a one year low of $2.58 and a one year high of $2.92.

TransEnterix (NYSEAMERICAN:TRXC) last posted its quarterly earnings results on Tuesday, May 8th. The medical instruments supplier reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. The business had revenue of $4.77 million during the quarter, compared to analyst estimates of $3.81 million. TransEnterix had a negative net margin of 21,045.36% and a negative return on equity of 137.69%.

Several brokerages have commented on TRXC. Zacks Investment Research upgraded shares of TransEnterix from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 9th. BTIG Research upgraded shares of TransEnterix from a “neutral” rating to a “buy” rating in a report on Wednesday, May 9th.

TransEnterix Company Profile

TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.

Institutional Ownership by Quarter for TransEnterix (NYSEAMERICAN:TRXC)

Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Expeditors International  – Analysts’ Weekly Ratings Updates
Expeditors International – Analysts’ Weekly Ratings Updates
Ranger Energy Services  – Research Analysts’ Recent Ratings Changes
Ranger Energy Services – Research Analysts’ Recent Ratings Changes
Geode Capital Management LLC Has $2.32 Billion Stake in Visa
Geode Capital Management LLC Has $2.32 Billion Stake in Visa
Steel Canyon Capital LLC Sells 3,200 Shares of Alphabet Inc.
Steel Canyon Capital LLC Sells 3,200 Shares of Alphabet Inc.
Millennium Management LLC Trims Stake in TransEnterix, Inc.
Millennium Management LLC Trims Stake in TransEnterix, Inc.
FDx Advisors Inc. Lowers Holdings in PRA Group
FDx Advisors Inc. Lowers Holdings in PRA Group


Leave a Reply

© 2006-2018 Ticker Report. Google+.